Genmab Poised to Triple Japan Staff for Stand-Alone Biz, First Up Is ADC for Cervical Cancer

Mika Takaki, President, Genmab K.K. Danish antibody powerhouse Genmab A/S is gearing up for stand-alone marketing in Japan, with an eye to the cervical cancer treatment tisotumab vedotin to start with. The company’s Japan chief Mika Takaki sat with Jiho...read more